Lindskog Hans
About Lindskog Hans
Lindskog Hans is a Key Account Manager with extensive experience in immunology and rheumatology, currently working at UCB in Sweden.
Title: Key Account Manager
Lindskog Hans holds the position of Key Account Manager in Southern Sweden. In this role, he is responsible for managing a portfolio of key accounts, developing client relationships, and contributing to the company's business growth in the region. His current tenure focuses on expanding market presence and maintaining high levels of customer satisfaction.
Career at Bristol-Myers Squibb
Lindskog Hans worked as a Scientific Advisor in Immunology/Rheumatology at Bristol-Myers Squibb (BMS) in Sweden from 2016 to 2017. During his time at BMS, he secured a project that mapped organ damage in SLE in collaboration with a Swedish university rheumatology clinic. Additionally, he arranged advisory boards and lecture events for international rheumatologists, significantly contributing to the field of ImmunoScience.
Territory Business Manager Experience
From 2008 to 2017, Lindskog Hans served as a Territory Business Manager in Sweden. His responsibilities included managing business operations within the specified territory, liaising with healthcare professionals, and ensuring product availability and market penetration. His extensive experience in this role provided him with a deep understanding of the pharmaceutical market dynamics in the region.
Educational Background
Lindskog Hans has a diverse educational background. He studied at Apotekarsocieteten where he undertook a marketing and advertising course and completed the IMA course in 2017. At Läkemedelsindustriföreningen LIF Sweden, he studied Pharmacy and achieved the LIF examination in 1997. He holds a Bachelor's Degree in Registered Nursing from Vårdhögsskolan Halmstad Varberg, completed in 1988. Additionally, he graduated from Halmstad University with qualifications in Economics, Marketing, and IT in 1997.
Significant Contributions and Projects
Throughout his career, Lindskog Hans has led and contributed to several initiatives. He managed 10-20 peer-to-peer meetings annually since 2009, focusing on topics such as experimental meetings, immunology, safety, and nursing. He organized four round table meetings for rheumatologists to share experiences. While working at MSD Medical for seven months starting in December 2007, he focused on obesity and lipid studies. At Sanofi-Winthrop from 1997 to 1999, he concentrated on cardiovascular products, achieving significant sales growth for Arcoxia in southern Sweden from 5.8% market share in June 2005 to 12.4% in May 2007, and contributed to the inclusion of Arcoxia in premedication for plastic surgery and post-op knee prosthesis operations.